| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |